CG Oncology
CGON
79.47
-2.43
-2.97%
CG Oncology
US · CGON
#1929 by market cap
Listed 2024
79.47
-2.43
-2.97%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Recent news
-
Rating change
Bank of America Securities Reaffirms Their Buy Rating on CG Oncology, Inc. (CGON)TipRanks · 2026/8/7
-
Rating change
Morgan Stanley Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $93Market Newswire · 2026/8/17
-
Rating change
Analysts' Opinions Are Mixed on These Healthcare Stocks: CG Oncology, Inc. (CGON) and Zimmer Biomet Holdings (ZBH)TipRanks · 2026/8/13
-
Guggenheim Maintains CG Oncology(CGON.US) With Buy Rating, Cuts Target Price to $89Market Newswire · 2026/11/9
-
Rating change
A Quick Look at Today's Ratings for CG Oncology(CGON.US), With a Forecast Between $85 to $108Market Newswire · 2026/8/8
-
Rating change
Analysts' Top Healthcare Picks: Annexon Biosciences (ANNX), CG Oncology, Inc. (CGON)TipRanks · 2026/8/7
-
Rating change
Analysts' Top Healthcare Picks: InflaRx (IFRX), CG Oncology, Inc. (CGON)TipRanks · 2026/8/7
-
Wedbush Maintains CG Oncology(CGON.US) With Buy Rating, Raises Target Price to $84Market Newswire · 2026/11/9
-
Rating change
A Quick Look at Today's Ratings for CG Oncology(CGON.US), With a Forecast Between $79 to $100Market Newswire · 2026/8/7
-
JonesTrading Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $85Market Newswire · 2026/11/7
-
Morgan Stanley Maintains CG Oncology(CGON.US) With Buy Rating, Raises Target Price to $102Market Newswire · 2026/11/13
-
Rating change
CG Oncology, Inc. (CGON) Gets a Buy From Piper SandlerTipRanks · 2026/8/7
-
Rating change
CG Oncology, Inc. (CGON) Initiated With a Buy at GuggenheimTipRanks · 2026/10/22
-
Rating change
UBS Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $90Market Newswire · 2026/8/21
-
Rating change
Analysts' Top Healthcare Picks: CG Oncology, Inc. (CGON), Opus Genetics (IRD)TipRanks · 2026/9/10
-
Rating change
LifeSci Capital Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $108Market Newswire · 2026/7/28
-
H.C. Wainwright Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $100Market Newswire · 2026/11/7
-
Rating change
UBS Keeps Their Buy Rating on CG Oncology, Inc. (CGON)TipRanks · 2026/8/20
-
Rating change
Truist Financial Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $85Market Newswire · 2026/8/13
-
Rating change
Truist Financial Maintains CG Oncology(CGON.US) With Buy RatingMarket Newswire · 2026/9/10
-
Rating change
H.C. Wainwright Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $100Market Newswire · 2026/7/29
-
Rating change
Analysts Have Conflicting Sentiments on These Healthcare Companies: Phibro Animal Health (PAHC), Universal Health (UHS) and CG Oncology, Inc. (CGON)TipRanks · 2026/7/28
-
Rating change
RBC Capital Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $81Market Newswire · 2026/6/30
-
Rating change
Analysts Offer Insights on Healthcare Companies: ATyr Pharma (ATYR) and CG Oncology, Inc. (CGON)TipRanks · 2026/7/10
-
Rating change
Analysts Offer Insights on Healthcare Companies: CG Oncology, Inc. (CGON), Alnylam Pharma (ALNY) and Connect Biopharma Holdings (CNTB)TipRanks · 2026/6/30
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 20:02:23 · For reference only, not investment advice and not tailored to your situation.
CG Oncology discussion 0 comments